Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis

Published:2024-01-05 Issue:2 Volume:57 Page:194-203
ISSN:1573-742X
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Zhou Qiang,Liu Xiang,Gu Zhi-Chun,Yang Xian,Huang Xiao-hui,Wu Yan-zi,Tao Ying-ying,Wei Meng

Funder

Innovative Research Group Project of the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11239-023-02919-2.pdf

Reference42 articles.

1. Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42(5):373–498

2. Ogilvie IM, Newton N, Welner Sharon A et al (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123(7):638–645

3. Kong B, Liu Y, Huang H et al (2015) Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives. J Thorac Dis 7(2):199–203

4. January CT, Wann LS, Calkins H et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines and the heart rhythm society in collaboration with the Society of thoracic surgeons. Circulation 140(2):e125–151

5. Osmancik P, Herman D, Neuzil P et al (2022) 4-Year outcomes after left atrial appendage Closure Versus nonwarfarin oral anticoagulation for Atrial Fibrillation. J Am Coll Cardiol 79(1):1–14